Home › Peanut Hypersensitivity › Massachusetts
Peanut Hypersensitivity clinical trials in Massachusetts
6 studies for Peanut Hypersensitivity are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit, Boston
- Boston Children's Hospital: Allergy and Asthma Program, Boston
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Boston Children's Hospital: Allergy and Asthma Program, Boston
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07279467Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Massachusetts General Hospital, Boston
RecruitingPhase 1Healthy volunteers welcome
Ages 12 to 55 · All sexes · Updated Aug 25, 2026 · NCT07287033Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- Massachusetts General Hospital, Boston
- Boston's Children's Hospital, Boston
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Jul 28, 2026 · NCT07220811Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
- Boston Children's Hospital, Boston
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Aug 24, 2025 · NCT05695261VE416 for Treatment of Food Allergy
- Massachusetts General Hospital, Boston
RecruitingPhase 1/2
Ages 12 to 55 · All sexes · Updated Oct 18, 2023 · NCT03936998From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.